PI4KA and breast carcinoma: Moreover, recent papers characterized a regulatory mechanism underlying sialylation in MDA-MB-231 breast cancer cells, mediated by the regulatory interplay between integrin α3β1-PI(4)Kα and GOLPH3-α3-sialyltransferase [57,63,64].